As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.
In this webinar, James Kirby, Director of the Clinical Microbiology Laboratory at Beth Israel Deaconess Medical Center, will discuss his lab’s experience establishing quantitative SARS-CoV-2 viral load testing, the clinical relevance of limits of detection and viral load, and the need to benchmark against a universal standard to allow cross-comparison of SARS-CoV-2 detection methods. He will also discuss the importance of validating the clinical sensitivity of SARS-CoV-2 testing platforms.
Russell Garlick, Chief Scientific Officer LGC SeraCare, will present the technologies used to advance reference materials for assay standardization.
The webinar will include a 15-minute Q&A session.